Austrian e-Health Terminology Browser
2.8.2+20250401 - TerminoloGit

ValueSet: DGC_MedicinalProduct

Summary

Defining URL:https://termgit.elga.gv.at/ValueSet/dgc-medicinalproduct
Version:2.1.0+20230731
Name:dgc-medicinalproduct
Title:DGC_MedicinalProduct
Status:Retired as of 2023-07-31
Definition:

To be used in certificate 2

OID:1.2.40.0.34.6.0.10.57 ({0} (for OID based terminology systems))

References

This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)

Logical Definition (CLD)

Generated Narrative: ValueSet dgc-medicinalproduct

  • Include these codes as defined in https://termgit.elga.gv.at/CodeSystem/eimpf-impfstoffe version 2.6.0+20230724
    CodeDisplayconcept_beschreibungrelationshipshinweiseDeutsch (Österreich) (German (Austria), de)
    4990459VAXZEVRIA COV19 10x10Vaxzevria1.2.40.0.34.4.17:EU/1/21/1529COVID-19 Vaccine AstraZeneca Injektionssuspension, COVID-19-Impfstoff (ChAdOx1-S [rekombinant])
    5424472PFIZER-BION COV19 KONZ30 1x6Comirnaty1.2.40.0.34.4.17:EU/1/20/1528Pfizer BioNTech COVID 19 Vaccine Suspension for Intramuscular Injection
    4989539COMIRNATY COV19 KONZ30 195x6Comirnaty1.2.40.0.34.4.17:EU/1/20/1528Comirnaty Konzentrat zur Herstellung einer Injektionsdispersion, COVID-19-mRNA-Impfstoff (Nukleosid-modifiziert)
    5506342COMIRNATY COV19 INJ30 195x6Comirnaty1.2.40.0.34.4.17:EU/1/20/1528Comirnaty 30 Mikrogramm/Dosis Injektionsdispersion; COVID-19-mRNA-Impfstoff (Nukleosid-modifiziert)
    5506359COMIRNATY COV19 INJ30 10x6Comirnaty1.2.40.0.34.4.17:EU/1/20/1528Comirnaty 30 Mikrogramm/Dosis Injektionsdispersion; COVID-19-mRNA-Impfstoff (Nukleosid-modifiziert)
    5506448COMIRNATY COV19 KONZ10 10x10Comirnaty1.2.40.0.34.4.17:EU/1/20/1528Comirnaty 10 Mikrogramm/Dosis Konzentrat zur Herstellung einer Injektionsdispersion; COVID-19-mRNA-Impfstoff (Nukleosid-modifiziert)
    4991720JCOVDEN COV19 10x5Jcovden1.2.40.0.34.4.17:EU/1/20/1525COVID-19 Vaccine Janssen Injektionssuspension, COVID-19-Impfstoff (Ad26.COV2-S [rekombinant])
    5502522JCOVDEN COV19 20x5Jcovden1.2.40.0.34.4.17:EU/1/20/1525COVID-19 Vaccine Janssen Injektionssuspension, COVID-19-Impfstoff (Ad26.COV2-S [rekombinant])
    5426867MODERNA/SPIKEVAX COV19 1x10Spikevax (previously COVID-19 Vaccine Moderna)1.2.40.0.34.4.17:EU/1/20/1507COVID-19 Vaccine Moderna, Injektionsdispersion, COVID-19-mRNA-Impfstoff (Nukleosid-modifiziert)
    5426873MODERNA/SPIKEVAX COV19 10x10Spikevax (previously COVID-19 Vaccine Moderna)1.2.40.0.34.4.17:EU/1/20/1507COVID-19 Vaccine Moderna, Injektionsdispersion, COVID-19-mRNA-Impfstoff (Nukleosid-modifiziert)
    5611903NUVAXOVID COV19 1x10Nuvaxovid1.2.40.0.34.4.17:EU/1/21/1618Nuvaxovid Injektionsdispersion; COVID-19 Impfstoff (rekombinant, adjuvantiert)
    5506431VALNEVA COV19 10x10Valneva1.2.40.0.34.4.17:EU/1/21/1624COVID-19-Impfstoff (inaktiviert, adjuvantiert) Valneva Injektionssuspension; COVID-19-Impfstoff (inaktiviert, adjuvantiert, adsorbiert)
    5516820COMIRNATY COV19 BA1 195x6Comirnaty1.2.40.0.34.4.17:EU/1/20/1528Comirnaty Original/Omicron BA.1 (15/15 Mikrogramm)/Dosis Injektionsdispersion; COVID-19-mRNA-Impfstoff (Nukleosid-modifiziert)
    5516837COMIRNATY COV19 BA1 10x6Comirnaty1.2.40.0.34.4.17:EU/1/20/1528Comirnaty Original/Omicron BA.1 (15/15 Mikrogramm)/Dosis Injektionsdispersion; COVID-19-mRNA-Impfstoff (Nukleosid-modifiziert)
    5516843COMIRNATY COV19 BA4/5 195x6Comirnaty1.2.40.0.34.4.17:EU/1/20/1528Comirnaty Original/Omicron BA.4-5 (15/15 Mikrogramm)/Dosis Injektionsdispersion; COVID-19-mRNA-Impfstoff (Nukleosid-modifiziert)
    5516866COMIRNATY COV19 BA4/5 10x6Comirnaty1.2.40.0.34.4.17:EU/1/20/1528Comirnaty Original/Omicron BA.4-5 (15/15 Mikrogramm)/Dosis Injektionsdispersion; COVID-19-mRNA-Impfstoff (Nukleosid-modifiziert)
    5517245SPIKEVAX COV19 BA1 10x5Spikevax (previously COVID-19 Vaccine Moderna)1.2.40.0.34.4.17:EU/1/20/1507Spikevax bivalent Original/Omicron BA.1 (50 Mikrogramm/50 Mikrogramm)/mL Injektionsdispersion; COVID-19-mRNA-Impfstoff (Nukleosid-modifiziert)
    AUSL_000001COVID-19-Impfstoff CVnCoV (CureVac)CVnCoV1.2.40.0.34.3.1.2.14.1:CVnCoV
    AUSL_000002COVID-19-Impfstoff NVX-CoV2373 (Novavax)NVX-CoV23731.2.40.0.34.3.1.2.14.1:NVX-CoV2373DEPRECATED
    AUSL_000003COVID-19-Impfstoff Sputnik-V (Gamaleya)Sputnik-V1.2.40.0.34.3.1.2.14.1:Sputnik-V
    AUSL_000004COVID-19-Impfstoff Convidecia (CanSino Biologics)Convidecia1.2.40.0.34.3.1.2.14.1:Convidecia
    AUSL_000005COVID-19-Impfstoff EpiVacCorona (Vektor-Institut)EpiVacCorona1.2.40.0.34.3.1.2.14.1:EpiVacCorona
    AUSL_000006COVID-19-Impfstoff BBIBP-CorV (Sinopharm)BBIBP-CorV1.2.40.0.34.3.1.2.14.1:BBIBP-CorV
    AUSL_000007COVID-19-Impfstoff Inactivated-SARS-CoV-2-Vero-CellInactivated SARS-CoV-2 (Vero Cell)1.2.40.0.34.3.1.2.14.1:Inactivated-SARS-CoV-2-Vero-CellDEPRECATED
    AUSL_000008COVID-19-Impfstoff CoronaVac (Sinovac Biotech)CoronaVac1.2.40.0.34.3.1.2.14.1:CoronaVac
    AUSL_000009COVID-19-Impfstoff Covaxin (Bharat Biotech)Covaxin (also known as BBV152 A, B, C)1.2.40.0.34.3.1.2.14.1:Covaxin
    AUSL_000010COVID-19-Impfstoff Covishield (Serum Institute of India)Covishield (ChAdOx1_nCoV-19)1.2.40.0.34.3.1.2.14.1:Covishield
    AUSL_000011COVID-19-Impfstoff Covid-19 (recombinant) (Fiocruz)Covid-19 (recombinant)1.2.40.0.34.3.1.2.14.1:Covid-19-recombinant
    AUSL_000012COVID-19-Impfstoff R-COVI (R-Pharm CJSC)R-COVI1.2.40.0.34.3.1.2.14.1:R-COVI
    AUSL_000013COVID-19-Impfstoff CoviVac (Chumakov-Federal-Scientific-Center)CoviVac1.2.40.0.34.3.1.2.14.1:CoviVac
    AUSL_000014COVID-19-Impfstoff Sputnik-Light (Gamaleya)Sputnik-Light1.2.40.0.34.3.1.2.14.1:Sputnik-Light
    AUSL_000015COVID-19-Impfstoff Hayat-Vax (Gulf Pharmaceutical Industries)Hayat-Vax1.2.40.0.34.3.1.2.14.1:Hayat-Vax
    AUSL_000016COVID-19-Impfstoff Abdala (Center for Genetic Engineering and Biotechnology)Abdala1.2.40.0.34.3.1.2.14.1:Abdala
    AUSL_000017COVID-19-Impfstoff WIBP-CorV (Sinopharm - Wuhan Institute of Biological Products)WIBP-CorV1.2.40.0.34.3.1.2.14.1:WIBP-CorV
    AUSL_000018COVID-19-Impfstoff MVC COVID-19 vaccine (Medigen Vaccine Biologics Corporation)MVC-COV19011.2.40.0.34.3.1.2.14.1:MVC-COV1901
    AUSL_000019COVID-19-Impfstoff Covovax (Serum Institute Of India Private Limited)Covovax1.2.40.0.34.3.1.2.14.1:Covovax
    AUSL_000020COVID-19-Impfstoff Vidprevtyn (Sanofi Pasteur)Vidprevtyn1.2.40.0.34.3.1.2.14.1:VidprevtynDEPRECATED
    AUSL_000021COVID-19-Impfstoff VLA2001 (Valneva France)VLA20011.2.40.0.34.3.1.2.14.1:VLA2001DEPRECATED
    AUSL_000022COVID-19-Impfstoff EpiVacCorona-N (Vector Institute)EpiVacCorona-N1.2.40.0.34.3.1.2.14.1:EpiVacCorona-N
    AUSL_000023COVID-19-Impfstoff Sputnik-M (Gamaleya Research Institute)Sputnik-M1.2.40.0.34.3.1.2.14.1:Sputnik-M
    AUSL_000024COVID-19-Impfstoff Vacina adsorvida covid-19 (inativada) (Instituto Butantan)Vacina adsorvida covid-19 (inativada)1.2.40.0.34.3.1.2.14.1:Covid-19-adsorvida-inativada
    AUSL_000025COVID-19-Impfstoff NVSI-06-08 (National Vaccine and Serum Institute, China)NVSI-06-081.2.40.0.34.3.1.2.14.1:NVSI-06-08
    AUSL_000026COVID-19-Impfstoff YS-SC2-010 (Yisheng Biopharma)YS-SC2-0101.2.40.0.34.3.1.2.14.1:YS-SC2-010
    AUSL_000027COVID-19-Impfstoff SCTV01C (Sinocelltech Ltd.)SCTV01C1.2.40.0.34.3.1.2.14.1:SCTV01C
    AUSL_000028COVID-19-Impfstoff Covifenz (Medicago Inc.)Covifenz1.2.40.0.34.3.1.2.14.1:Covifenz
    AUSL_000029COVID-19-Impfstoff AZD2816 (AstraZeneca AB)AZD28161.2.40.0.34.3.1.2.14.1:AZD2816
    AUSL_000030COVID-19-Impfstoff Soberana 02 (Finlay-Institute)Soberana 021.2.40.0.34.3.1.2.14.1:Soberana-02
    AUSL_000031COVID-19-Impfstoff Soberana Plus (Finlay-Institute)Soberana Plus1.2.40.0.34.3.1.2.14.1:Soberana-Plus
    5517831SPIKEVAX COV19 BA1 FSPR 10x1Spikevax (previously COVID-19 Vaccine Moderna)1.2.40.0.34.4.17:EU/1/20/1507Spikevax bivalent Original/Omicron BA.1 (25 Mikrogramm / 25 Mikrogramm) Injektionsdispersion in einer Fertigspritze; COVID-19-mRNA-Impfstoff (Nukleo…
    5517825SPIKEVAX COV19 BA1 10x1Spikevax (previously COVID-19 Vaccine Moderna)1.2.40.0.34.4.17:EU/1/20/1507Spikevax bivalent Original/Omicron BA.1 (25 Mikrogramm / 25 Mikrogramm) Injektionsdispersion; COVID-19-mRNA-Impfstoff (Nukleosid-modifiziert)
    5517015COMIRNATY KO5/5 BA4/5 10x10Comirnaty1.2.40.0.34.4.17:EU/1/20/1528Comirnaty Original/Omicron BA.4-5 (5/5 Mikrogramm)/Dosis Konzentrat zur Herstellung einer Injektionsdispersion; COVID-19-mRNA-Impfstoff (Nukleosid-m…
    5516984COMIRNATY KO3 10x10Comirnaty1.2.40.0.34.4.17:EU/1/20/1528Comirnaty 3 Mikrogramm/Dosis Konzentrat zur Herstellung einer Injektionsdispersion; COVID-19-mRNA-Impfstoff (Nukleosid-modifiziert)
    5516990COMIRNATY KO1,5/1,5 10x10Comirnaty1.2.40.0.34.4.17:EU/1/20/1528Comirnaty Original/Omicron BA.4-5 (1,5/1,5 Mikrogramm)/Dosis Konzentrat zur Herstellung einer Injektionsdispersion; COVID-19-mRNA-Impfstoff (Nukleos…
    5517908VIDPREVTYN COV19 10x10VidPrevtyn1.2.40.0.34.4.17:EU/1/21/1580VidPrevtyn Beta Lösung und Emulsion zur Herstellung einer Emulsion zur Injektion COVID-19-Impfstoff (rekombinant, adjuvantiert)
    5518730SPIKEVAX COV19 BA4/5 10x5Spikevax (previously COVID-19 Vaccine Moderna)1.2.40.0.34.4.17:EU/1/20/1507Spikevax bivalent Original/Omicron BA.4-5 (50 Mikrogramm/50 Mikrogramm)/ml Injektionsdispersion; COVID-19-mRNA-Impfstoff (Nukleosid-modifiziert)
    5520483SPIKEVAX COV19 BA4/5 10x1Spikevax (previously COVID-19 Vaccine Moderna)1.2.40.0.34.4.17:EU/1/20/1507Spikevax bivalent Original/Omicron BA.4-5 25 Mikrogramm/25 Mikrogramm/ml Injektionsdispersion; COVID-19-mRNA-Impfstoff (Nukleosid-modifiziert)

 

Expansion

Expansions are not generated for retired value sets

Explanation of the columns that may appear on this page:

LevelA few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
SystemThe source of the definition of the code (when the value set draws in codes defined elsewhere)
CodeThe code (used as the code in the resource instance)
DisplayThe display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
DefinitionAn explanation of the meaning of the concept
CommentsAdditional notes about how to use the code